Ginger for Blood Sugar
Ginger is the most interesting entry in this section for a reason that has nothing to do with ginger: it is a clean worked example of two competent meta-analyses reaching opposite conclusions about the same question. Anyone who wants to understand why supplement evidence is hard should read both.
Evidence tier 3, contested. The pooled results disagree, and which one you read determines what you conclude.
Table of Contents
Two Meta-Analyses, Two Answers
Chen and colleagues' 2026 meta-analysis in Systematic Reviews pooled 13 trials and found ginger supplementation significantly reduced fasting blood sugar by 16.27 mg/dL (95% CI −25.75 to −6.80) and HbA1c by 0.41 percentage points in type 2 diabetes. On its own that is a respectable effect, comparable to some pharmaceutical add-ons.
Schumacher and colleagues' 2024 systematic review in Clinical Nutrition ESPEN included five trials of 1.2–2 g/day over 4–12 weeks and found no significant effect of ginger on glycemic control in type 2 diabetes.
Both are peer-reviewed, both are recent, and they disagree. The usual explanations are inclusion criteria (13 trials versus 5 — the larger review admitted studies the smaller one excluded), heterogeneity (the 2026 analysis reports I² = 86% for fasting glucose, meaning its component trials disagreed sharply with each other), and the small, variable, often unblinded nature of the underlying studies.
High heterogeneity is the detail to take away. An I² of 86% means the pooled average is being computed across trials that do not tell the same story, and an average of disagreeing studies is a much weaker object than the same average across consistent ones. When a field looks like this, the honest position is uncertainty, not picking the answer you prefer.
Mechanism
Gingerols and shogaols — the pungent principles, the latter formed when ginger is dried or heated — have been reported to increase GLUT4 translocation to the muscle cell membrane, inhibit intestinal α-glucosidase, and reduce inflammatory signalling. As with the rest of this section, these are preclinical observations proposed to explain a clinical effect whose existence is exactly what is in dispute.
Where It Fits
Ginger's well-supported uses are elsewhere: nausea in pregnancy, motion sickness and chemotherapy-induced nausea have far better evidence than anything on this page. For blood sugar it is a reasonable culinary habit and a poor primary strategy.
Trial doses cluster around 1–2 g/day of dried powdered ginger. If you want to test it on yourself, that range and a monitor will tell you more about your own response than either meta-analysis will.
Cautions
- It lowers blood glucose, and so does your medication. The effects add. With insulin or a sulfonylurea this is a hypoglycemia risk, and dose changes belong with the prescriber — see hypoglycemia awareness and prevention.
- Antiplatelet activity at supplemental doses — relevant with anticoagulants and before surgery.
- Heartburn and reflux are the common complaints at gram doses.
- Measure, do not assume. Adding a supplement without measuring means you learn about an interaction from a symptom rather than from a number.
Key Research Papers
Every DOI below was checked against Crossref and the abstract read for support before it was listed.
- Chen, et al. Meta-analysis of the effects of ginger supplementation on glycemic control, blood pressure and lipid profile in patients with type 2 diabetes. Systematic Reviews, 2026;15(1):231. Thirteen trials; significant reductions, with I² = 86%.
- Schumacher, et al. The effect of oral supplementation of ginger on glycemic control of patients with type 2 diabetes mellitus — a systematic review and meta-analysis. Clinical Nutrition ESPEN, 2024;63:615–622. Five trials; no significant effect.